O Gureje1, S Seedat2, L Kola1, J Appiah-Poku3, C Othieno4, B Harris5, V Makanjuola1, L N Price6, O O Ayinde1, O Esan1. 1. University of Ibadan,Ibadan,Nigeria. 2. Stellenbosch University,Cape Town,South Africa. 3. Kwame Nkrumah University of Science and Technology,Kumasi,Ghana. 4. University of Nairobi,Nairobi,Kenya. 5. University of Liberia,Monrovia,Liberia. 6. Department of Health and Human Services,National Institute of Mental Health, National Institutes of Health,Bethesda, MD,USA.
Abstract
AimsIn low- and middle-income countries (LMIC) in general and sub-Sahara African (SSA) countries in particular, there is both a large treatment gap for mental disorders and a relative paucity of empirical evidence about how to fill this gap. This is more so for severe mental disorders, such as psychosis, which impose an additional vulnerability for human rights abuse on its sufferers. A major factor for the lack of evidence is the few numbers of active mental health (MH) researchers on the continent and the distance between the little evidence generated and the policy-making process. METHODS: The Partnership for Mental Health Development in Africa (PaM-D) aimed to bring together diverse MH stakeholders in SSA, working collaboratively with colleagues from the global north, to create an infrastructure to develop MH research capacity in SSA, advance global MH science by conducting innovative public health-relevant MH research in the region and work to link research to policy development. Participating SSA countries were Ghana, Kenya, Liberia, Nigeria and South Africa. The research component of PaM-D focused on the development and assessment of a collaborative shared care (CSC) program between traditional and faith healers (T&FHs) and biomedical providers for the treatment of psychotic disorders, as a way of improving the outcome of persons suffering from these conditions. The capacity building component aimed to develop research capacity and appreciation of the value of research in a broad range of stakeholders through bespoke workshops and fellowships targeting specific skill-sets as well as mentoring for early career researchers. RESULTS: In the research component of PaM-D, a series of formative studies were implemented to inform the development of an intervention package consisting of the essential features of a CSC for psychosis implemented by primary care providers and T&FHs. A cluster randomised controlled trial was next designed to test the effectiveness of this package on the outcome of psychosis. In the capacity-building component, 35 early and mid-career researchers participated in the training workshops and several established mentor-mentee relationships with senior PaM-D members. At the end of the funding period, 60 papers have been published and 21 successful grant applications made. CONCLUSION: The success of PaM-D in energising young researchers and implementing a cutting-edge research program attests to the importance of partnership among researchers in the global south working with those from the north in developing MH research and service in LMIC.
AimsIn low- and middle-income countries (LMIC) in general and sub-Sahara African (SSA) countries in particular, there is both a large treatment gap for mental disorders and a relative paucity of empirical evidence about how to fill this gap. This is more so for severe mental disorders, such as psychosis, which impose an additional vulnerability for human rights abuse on its sufferers. A major factor for the lack of evidence is the few numbers of active mental health (MH) researchers on the continent and the distance between the little evidence generated and the policy-making process. METHODS: The Partnership for Mental Health Development in Africa (PaM-D) aimed to bring together diverse MH stakeholders in SSA, working collaboratively with colleagues from the global north, to create an infrastructure to develop MH research capacity in SSA, advance global MH science by conducting innovative public health-relevant MH research in the region and work to link research to policy development. Participating SSA countries were Ghana, Kenya, Liberia, Nigeria and South Africa. The research component of PaM-D focused on the development and assessment of a collaborative shared care (CSC) program between traditional and faith healers (T&FHs) and biomedical providers for the treatment of psychotic disorders, as a way of improving the outcome of persons suffering from these conditions. The capacity building component aimed to develop research capacity and appreciation of the value of research in a broad range of stakeholders through bespoke workshops and fellowships targeting specific skill-sets as well as mentoring for early career researchers. RESULTS: In the research component of PaM-D, a series of formative studies were implemented to inform the development of an intervention package consisting of the essential features of a CSC for psychosis implemented by primary care providers and T&FHs. A cluster randomised controlled trial was next designed to test the effectiveness of this package on the outcome of psychosis. In the capacity-building component, 35 early and mid-career researchers participated in the training workshops and several established mentor-mentee relationships with senior PaM-D members. At the end of the funding period, 60 papers have been published and 21 successful grant applications made. CONCLUSION: The success of PaM-D in energising young researchers and implementing a cutting-edge research program attests to the importance of partnership among researchers in the global south working with those from the north in developing MH research and service in LMIC.
Entities:
Keywords:
Mental health; Sub-Saharan Africa; partnership; research
Authors: Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos Journal: Lancet Date: 2013-08-29 Impact factor: 79.321
Authors: Johan Ormel; Maria Petukhova; Somnath Chatterji; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Evelyn J Bromet; Huibert Burger; Koen Demyttenaere; Giovanni de Girolamo; Josep Maria Haro; Irving Hwang; Elie Karam; Norito Kawakami; Jean Pierre Lépine; María Elena Medina-Mora; José Posada-Villa; Nancy Sampson; Kate Scott; T Bedirhan Ustün; Michael Von Korff; David R Williams; Mingyuan Zhang; Ronald C Kessler Journal: Br J Psychiatry Date: 2008-05 Impact factor: 9.319
Authors: A S J van der Watt; T van de Water; G Nortje; B D Oladeji; S Seedat; O Gureje Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-04-25 Impact factor: 4.328
Authors: Alberta S J van der Watt; Gareth Nortje; Lola Kola; John Appiah-Poku; Caleb Othieno; Benjamin Harris; Bibilola D Oladeji; Oluyomi Esan; Victor Makanjuola; LeShawndra N Price; Soraya Seedat; Oye Gureje Journal: Qual Health Res Date: 2017-09-13
Authors: Lisa F Langhaug; Helen Jack; Charlotte Hanlon; Stefan Holzer; Katherine Sorsdahl; Barbara Mutedzi; Walter Mangezi; Christopher Merritt; Atalay Alem; Robert Stewart; Chiwoza Bandawe; Rosemary Musesengwa; Melanie Abas; Dixon Chibanda; Crick Lund Journal: Int J Ment Health Syst Date: 2020-08-14
Authors: Clara E Busse; Elizabeth W Anderson; Tamrat Endale; Yolanda Regina Smith; Marie Kaniecki; Carol Shannon; Ella T August Journal: BMJ Glob Health Date: 2022-02
Authors: Chifundo Colleta Zimba; Christopher F Akiba; Maureen Matewere; Annie Thom; Michael Udedi; Jones Kaponda Masiye; Kazione Kulisewa; Vivian Fei-Ling Go; Mina C Hosseinipour; Bradley Neil Gaynes; Brian Wells Pence Journal: Int J Ment Health Syst Date: 2021-06-11